MAPT and Alzheimer disease: It was also showed that intranasal insulin administration reversed the reduction of brain insulin signaling and tau hyperphosphorylation in the diabetic rat brains [12], which suggested that T2D might increase the risk for developing AD through the impairment of brain insulin signaling pathway.